Articles tagged with Vaccination
Many older adults plan extended trips, considering COVID-19 cases at their destination. Vaccinated adults face a lower risk of severe infection compared to unvaccinated peers. Most respondents would make necessary preparations for travel, such as bringing enough medications and medical supplies.
The CDC's four-tiered vaccine prioritization strategy outperformed most approaches in reducing deaths and cases, while some optimizations could improve outcomes. The study found that prioritizing healthcare workers and individuals under 16 was optimal, but strategies focusing on comorbidities were also effective.
Iowa State University researchers validated the CDC's COVID-19 vaccine rollout strategy, which prioritized frontline essential workers, older age groups, and individuals with underlying health factors. The model showed that this approach was highly effective in curbing mortality while keeping case numbers at bay.
A new nasal vaccine, Protollin, is being tested in humans for the first time to prevent and slow Alzheimer's disease progression. The trial aims to determine safety and tolerability, as well as its effects on the immune system.
Researchers at the Ragon Institute of MGH, MIT and Harvard have developed a new anti-malarial antibody that provides significant protection against malaria, outperforming existing best-in-class antibodies. The breakthrough could lead to improved distribution of monoclonal antibodies in endemic countries.
A study found that vaccination rates among Indian children improved significantly between 1992 and 2016, with a 70% drop in child mortality from vaccine-preventable diseases. However, zero-dose children remained concentrated among disadvantaged groups, including low-income households and mothers with limited education.
A proposal suggests that wealthier nations should pay a COVID-19 vaccine tax to support COVAX, an international initiative buying and distributing vaccines for the world's poorest. The tax would be proportional to how much they spend on jabs for their own populations.
States allowing minors to consent to HPV vaccination without parental involvement showed higher vaccine series initiation rates from 2015 to 2018, according to a JAMA Pediatrics analysis of nearly 82,000 adolescents. The study found increased vaccine uptake in these states compared to those with parental consent requirements.
A study found that linking health code colour to vaccination status in China could increase willingness to vaccinate by 8.61% among hesitant individuals. However, concerns about vaccine safety and effectiveness remain a barrier.
A new test can determine the presence of SARS-CoV-2 neutralising antibodies within 10 minutes, allowing for larger-scale screening and mass monitoring. The rapid cellulose pull-down viral neutralisation test has been developed using protein engineering technology and offers quick results with high accuracy.
A study published in JAMA Pediatrics found that mothers with disease-acquired immunity and those with vaccine-immunity produced high levels of antibodies in their breast milk, providing neutralization against SARS-CoV-2. The antibodies, including IgA and IgG, existed for three months after infection or vaccination.
Researchers investigated the impact of mRNA vaccines on dialysis patients' immunity against Sars-Cov-2 variants. They found that while many produce reactive T cells, protective antibodies are formed less frequently. This immunological memory can be strengthened through vaccination and repeated contact with the pathogen.
A KU study reveals that individuals' political ideologies play a crucial role in shaping their health behaviors during the COVID-19 pandemic. The research, conducted using two surveys and a review of existing data, found that ideology was a significant predictor of health behavior, especially when compared to other factors such as age,...
A study of 77 lactating parents found a higher prevalence of anti-SARS-CoV-2 antibodies in breast milk among unvaccinated mothers, suggesting potential protection against COVID-19. The study also identified a link between vaccine-induced immunity and increased neutralizing activity in human milk.
Researchers have developed innovative ways to avoid clouds of coronavirus in public waiting lines, classrooms, and live musical performances. Periodic movements in lines can cause aerosol transmission, while heating in winter and air conditioning in summer create 'dead zones' that spread airborne diseases.
A study of nearly 2000 healthcare workers found that being vaccinated against COVID-19 decreased asymptomatic SARS-CoV-2 infection detection compared to unvaccinated staff. Vaccination status was associated with reduced risk of infection.
A large group of patients with diverse cancer types received two doses of SARS-CoV-2 vaccines or one dose of the Johnson and Johnson vaccine, showing modestly impaired immune responses. Booster vaccine doses enhanced immunity in most patients.
The article highlights the critical need for routine vaccinations to recover from the COVID-19 pandemic. A decline in vaccine rates, particularly among children, poses a significant risk to future population health and overtaxes the healthcare system.
The article highlights the importance of recovering routine vaccination rates after the COVID-19 pandemic. Vaccinations for MMR, DTaP, polio, and HPV have seen significant drops, posing dire consequences to population health. Experts emphasize the need for stakeholders to drive awareness, facilitate access, and build vaccine confidence.
People with blood cancers are at higher risk of severe COVID-19 illness; research suggests they don't always achieve optimal protection from vaccination. A new study found that patients with lymphoma were more likely to develop post-vaccination COVID-19 infection compared to those with other blood cancers.
Researchers found that older individuals produce higher levels of protective antibodies after infection or vaccination, providing better defense against emerging variants. Antibodies from infected individuals 50+ years old reacted strongly to the Delta variant, outperforming those from vaccinated adults under 50.
Two new studies show that people who think they'll have an allergic reaction or believe they've had one to the first vaccine can still be fully vaccinated. The studies found that 100 patients with PEG allergies and 25 patients with adverse events following immunization tolerated the full vaccine series without severe symptoms.
Rutgers researchers have developed a new way to deliver DNA molecules into skin cells using suction technique similar to ancient healing practice of cupping. The method generated a strong immune response about 100 times stronger than an injected vaccine alone, leading to licensing for human clinical trials.
A pediatric practice in Rochester, NY, demonstrates success in vaccinating eligible patients and their caregivers during regular visits, showcasing a model for addressing vaccine hesitancy. The approach found positive outcomes, including increased comfort and trust among caregivers.
A national survey found that half of US vaccine hesitant individuals believe nothing will convince them to get vaccinated. Most cited concerns about vaccine safety as the reason for their unwillingness.
Researchers found a clear link between people's expectations and actual vaccine side effects, suggesting that psychological factors can predict which individuals will experience more symptoms. The study aims to help overcome lingering vaccine hesitancy by reframing the way we think about side effects.
COVID-19 vaccinations have been shown to be safe for advanced breast cancer patients, with no notable differences between vaccine brands. The second dose is crucial to induce an immune response, which has been found in 80% of patients with solid tumours.
Researchers will identify and track SARS-CoV-2 variants using genomic sequence analyses. The project aims to understand the emergence and spread of the virus in West Virginia, helping public health officials prepare for future outbreaks.
A new review highlights the complexity of vaccinating children under 12 years against COVID-19, weighing risk and benefit. The review suggests that further data is needed to confirm the vaccine's effectiveness in preventing disease in this age group.
A decision-support tool aided healthcare workers in distinguishing COVID-19 vaccination symptoms from actual infections, preserving the workforce during a surge. The study found that providing this guidance helped curb the spread of COVID-19 and reduced missed workdays.
A recent study estimates that the net manufacturing costs for 100 million doses of COVID-19 vaccine ready for shipping range from $0.54 to $0.98. Companies charge significantly higher prices, despite discounts and tiered pricing for low-income countries, which are likely to prolong the global pandemic.
A study of 8,889 vaccinated patients and 88,898 unvaccinated patients found the Ad26.COV2.S vaccine to be effective in reducing SARS-CoV-2 infection. The results support mass vaccination efforts globally amid variant spread.
A new report highlights the alarming global impact of Group B streptococcus, which can lead to up to 150,000 infant deaths annually. Maternal vaccination is seen as a cost-effective solution to reduce this toll, with significant health benefits in all regions.
Researchers at Johns Hopkins Medicine found that antibody levels against SARS-CoV-2 stay higher in people who were infected by the virus and then received protection from mRNA vaccine compared to those who only got vaccinated. A longer interval between virus exposure and first vaccine dose may enhance antibody response.
Conspiracy theorists used the conditional nature of science to erode trust in public health authorities' recommendations, making community immunity elusive. The Annenberg Public Policy Center scholar argues that exploiting scientific funding structures and updates fueled conspiracy theories.
A recent study published in JAMA Internal Medicine investigated the incidence of cerebral venous sinus thrombosis (CVST) after post-vaccination. The researchers found that the rate of this rare adverse effect is significantly higher than pre-pandemic rates, prompting consideration of vaccine effectiveness in preventing COVID-19.
Researchers at University of Queensland successfully protected mice from COVID-19 using a US-developed vaccine candidate delivered via a pocket-sized, pain-free applicator. The vaccine produced strong immune responses and neutralized multiple variants, including UK and South Africa variants.
A study by Massachusetts General Hospital found that prioritizing prompt procurement, distribution, and vaccination pace can maximize public health benefits and economic efficiency. Meeting vaccination targets of 67% or 80% of the population can significantly reduce infections and deaths while minimizing healthcare costs.
A massive Israeli study found that a third COVID-19 vaccine dose reduces hospitalization and severe disease risks by up to 93% compared to two doses. The research provides valuable insights into the effectiveness of booster shots in real-world settings.
A recent study published in the American Journal of Roentgenology found a link between COVID-19 mRNA vaccination and myocarditis in adolescent males. Cardiac MRI was used to assess suspected myocarditis post-vaccination, with late gadolinium enhancement persisting in two patients undergoing repeat MRI.
A study published in The Lancet Infectious Diseases found that COVID-19 vaccines reduce the risk of infection with the delta variant, but vaccinated people can still spread the virus in household settings. Vaccination remains effective at preventing severe disease and deaths from COVID-19.
A chatbot tested with 338 individuals showed a 37% increase in positive views of vaccination and a 20% decrease in vaccine refusal after just a few minutes of interaction. The study suggests that the chatbot could be an effective tool to reduce vaccine hesitancy.
A 51-country survey reveals that people who feel invincible to COVID-19 are less likely to get vaccinated and believe in the importance of individual actions. The study suggests that messaging emphasizing collective action is crucial in individualistic cultures.
The study found that the $25 Summer Card Pilot program successfully encouraged more adults to get a COVID-19 vaccine by halving the drop in vaccination rates. The program's design provided guaranteed financial incentives, which were particularly effective among low-income and minority groups.
A study published in International Journal of Molecular Sciences found that the Sputnik-V COVID vaccine elicits both robust antibody and T-cell responses. The research suggests that long-term immunity is possible, supporting the effectiveness of the vaccine against local virus variants.
A breakthrough oral vaccine candidate has been developed to prevent hookworm infection, which affects half a billion people worldwide. The vaccine triggers a strong immune response and reduces worm numbers by up to 94% in mice trials.
Researchers found nearly all employees with a history of severe allergic reactions could become fully vaccinated, despite higher reported symptoms. The study suggests COVID-19 vaccines are safe for individuals with high-risk allergy histories.
A pilot program in North Carolina found that offering incentive cash cards to adults who receive or drive someone to receive their first dose of COVID-19 vaccine significantly increases vaccination rates. The study suggests that guaranteed financial incentives can be an effective strategy to promote COVID-19 vaccination.
A survey of 299 adults and three experiments with over 1,324 participants found that 86% would get vaccinated if required for work, travel, or school. Vaccination requirements strengthened intentions to vaccinate, even among those who tend to react negatively to regulations.
A new study published in The New England Journal of Medicine has found no correlation between COVID-19 vaccinations and risk of first-trimester miscarriages. Vaccination during pregnancy is safe and provides protection to the newborn infant against COVID-19 infection.
A study published in the Atlantic Journal of Communication analyzed Instagram posts from 20 celebrity influencers about COVID-19 between March and May 2020. The researchers found that celebrities initially modeled guidance from health experts, normalizing suggested behaviors such as staying home and practicing hand hygiene.
Two studies confirm that COVID-19 vaccination significantly reduces both COVID-19 hospitalization rates and severe illnesses among adolescents aged 12-18. A CDC-supported study found two doses of the Pfizer-BioNTech vaccine to be 93% effective in preventing COVID-19 hospitalizations.
A study found that over half of double-vaccinated blood cancer patients have poor immune responses to COVID-19. Despite being vaccinated, these patients remain vulnerable to severe infection and are urged to continue wearing masks and maintaining social distancing.
Research from University of Pennsylvania team shows that vaccine mandates have positive effects on vaccination intentions, particularly for those who oppose forced behavior. Mandates strengthen vaccination intentions, regardless of racial or ethnic group, and for individuals with a disposition towards psychological reactance.
Researchers quantified COVID-19 vaccine uptake disparities by race and ethnicity within US states, revealing substantial coverage gaps among older adults. The study's findings underscore the need for targeted vaccination strategies to address these disparities.
A new study from Karolinska Institutet finds that two vaccine doses increase antibody levels in the airways after COVID-19, while a second dose after recovery also boosts levels. The results highlight the importance of completing vaccination with a second dose to achieve optimal immune responses and reduce transmission.
The study shows that COVID-19 vaccine effectiveness is substantial in adolescents, with a 93% decrease in symptomatic cases and a 90% decrease in documented infections after the second dose. Vaccine effectiveness was lower but still significant before the second dose.
Researchers at Osaka University developed a vaccine that offers cross-protection against SARS coronaviruses by targeting the conserved core region of the spike protein receptor-binding domain. This approach has the potential to protect against future outbreaks, including those caused by novel viruses.
Researchers at West Virginia University discovered a significant relationship between Christian nationalism and vaccine hesitancy, citing a national sample of 2,000 U.S. adults. They found that individuals embracing this ideology are less likely to receive the COVID-19 vaccine and express skepticism towards science.
A new study found that pregnant and lactating women need to adhere closely to recommended COVID-19 vaccine schedules to attain full antibody protection. Key antibody functions are delayed in these groups following the initial dose, but the second dose induces robust antibody responses similar to those in nonpregnant women.